CSIMarket


Aclaris Therapeutics, Inc.  (ACRS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


 

Aclaris Therapeutics, Inc.

ACRS's Financial Statements and Analysis



Aclaris Therapeutics, Inc. narrowed I. Quarter net loss per share of $-0.91 compare to net loss per share of $-0.98 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.99 realized in previous quarter.


I. Quarter
Earnings Per Share Revenues
$ -0.91 $  5 Mill
$+0.07     $+4M     +350.89 %



Aclaris Therapeutics's Revenue rose by 350.89 % in I. Quarter (Mar 31 2019) year on year, to $5 million and advanced by 37.39 % sequentially.


Aclaris Therapeutics is

More on ACRS's Income Statement



Aclaris Therapeutics's in I. Quarter recorded net loss of $-38 million, an increase from net loss of $-30 million in I. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-38.55 million realized in previous quarter.

More on ACRS's Growth

In I. Quarter company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -4.70%, to $-0 millions compare to same quarter a year ago and fell by 94.52% from IV. Quarter (Dec 31 2018).

More on ACRS's Cash flow Statement


Aclaris Therapeutics, Inc. does not pay out common stock dividend.

In trailing twelve-month period Aclaris Therapeutics, Inc. payed $ -2.67 cash per share, on a free-cash flow basis .

Book value fell by -20.26 % sequentially to $4.42 per share, -28.25% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 2.24 per share from $ 3.19.

Company issued 2.42 million shares or 6.24 % in I. Quarter.


More on ACRS's Dividends

 Market Capitalization (Millions) 91
 Shares Outstanding (Millions) 41
 Total Debt (Millions $) 30
 Revenue (TTM) (Millions $) 14
 Net Income (TTM) (Millions $) -140
 Cash Flow (TTM) (Millions $) -35
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Aclaris Therapeutics, Inc. does not pay out common stock dividend.

In trailing twelve-month period Aclaris Therapeutics, Inc. payed $ -2.67 cash per share, on a free-cash flow basis .

Book value fell by -20.26 % sequentially to $4.42 per share, -28.25% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 2.24 per share from $ 3.19.

Company issued 2.42 million shares or 6.24 % in I. Quarter.


More on ACRS's Balance Sheets

 Market Capitalization (Millions) 91
 Shares Outstanding (Millions) 41
 Total Debt (Millions $) 30
 Revenue (TTM) (Millions $) 14
 Net Income (TTM) (Millions $) -140
 Cash Flow (TTM) (Millions $) -35
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HCM's Profile

Stock Price

HCM's Financials

Business Description

Fundamentals

Charts & Quotes

HCM's News

Suppliers

HCM's Competitors

Customers & Markets

Economic Indicators

HCM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright Š 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071